FR2998570B1 - Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes - Google Patents

Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes

Info

Publication number
FR2998570B1
FR2998570B1 FR1261205A FR1261205A FR2998570B1 FR 2998570 B1 FR2998570 B1 FR 2998570B1 FR 1261205 A FR1261205 A FR 1261205A FR 1261205 A FR1261205 A FR 1261205A FR 2998570 B1 FR2998570 B1 FR 2998570B1
Authority
FR
France
Prior art keywords
peptides
compositions
same
cosmetic uses
particularly cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1261205A
Other languages
English (en)
Other versions
FR2998570A1 (fr
Inventor
Olivier Peschard
Philippe Mondon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1261205A priority Critical patent/FR2998570B1/fr
Application filed by Sederma SA filed Critical Sederma SA
Priority to US14/646,999 priority patent/US9534015B2/en
Priority to EP22214839.7A priority patent/EP4198041A3/fr
Priority to PCT/IB2013/060390 priority patent/WO2014080376A2/fr
Priority to EP13824175.7A priority patent/EP2922864B1/fr
Publication of FR2998570A1 publication Critical patent/FR2998570A1/fr
Priority to US15/361,801 priority patent/US10231917B2/en
Application granted granted Critical
Publication of FR2998570B1 publication Critical patent/FR2998570B1/fr
Priority to US16/259,176 priority patent/US10660839B2/en
Priority to US16/848,142 priority patent/US11324687B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1261205A 2012-11-26 2012-11-26 Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes Active FR2998570B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1261205A FR2998570B1 (fr) 2012-11-26 2012-11-26 Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
EP22214839.7A EP4198041A3 (fr) 2012-11-26 2013-11-25 Peptides cosmetiques
PCT/IB2013/060390 WO2014080376A2 (fr) 2012-11-26 2013-11-25 Peptides pro-pigmentants
EP13824175.7A EP2922864B1 (fr) 2012-11-26 2013-11-25 Peptides propigmentants
US14/646,999 US9534015B2 (en) 2012-11-26 2013-11-25 Pro-pigmenting peptides
US15/361,801 US10231917B2 (en) 2012-11-26 2016-11-28 Pro-pigmenting peptides
US16/259,176 US10660839B2 (en) 2012-11-26 2019-01-28 Pro-pigmenting peptides
US16/848,142 US11324687B2 (en) 2012-11-26 2020-04-14 Pro-pigmenting peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1261205A FR2998570B1 (fr) 2012-11-26 2012-11-26 Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes

Publications (2)

Publication Number Publication Date
FR2998570A1 FR2998570A1 (fr) 2014-05-30
FR2998570B1 true FR2998570B1 (fr) 2016-12-02

Family

ID=47666342

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1261205A Active FR2998570B1 (fr) 2012-11-26 2012-11-26 Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes

Country Status (4)

Country Link
US (4) US9534015B2 (fr)
EP (2) EP4198041A3 (fr)
FR (1) FR2998570B1 (fr)
WO (1) WO2014080376A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12017501070B1 (en) * 2014-12-23 2022-04-29 Avon Prod Inc Peptides and their use in the treatment of skin
FR3034314B1 (fr) 2015-03-30 2019-10-04 Sederma Traitement cosmetique topique de la peau et du cuir chevelu et ingredient actif correspondant a base d'un extrait d'apium graveolens
CN108472516B (zh) 2015-12-24 2021-10-26 联合利华知识产权控股有限公司 酪氨酸酶抑制剂
FR3049194B1 (fr) 2016-03-23 2019-10-04 Sederma Utilisation d’un ingredient cosmetique comprenant un materiel vegetal issu de marrubium vulgare pour un traitement cosmetique
FR3052453B1 (fr) 2016-06-14 2018-05-18 Sederma Peptide, composition le comprenant et utilisations notamment cosmetiques
EP3509618B1 (fr) * 2016-09-09 2021-03-03 Research Foundation Of The City University Of New York Polymère peptidique autoassemblé
FR3056400B1 (fr) 2016-09-27 2020-01-10 Sederma Traitement cosmetique des ongles
FR3056401B1 (fr) 2016-09-27 2020-01-10 Sederma Traitement cosmetique topique amincissant
FR3060569B1 (fr) * 2016-12-19 2021-02-12 Oreal Polypeptides pour favoriser la pigmentation des matieres keratiniques.
EP3562500B1 (fr) * 2016-12-27 2023-07-19 Adocia Compositions sous forme de solution aqueuse injectable comprenant de l'amyline, un agoniste au récepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
WO2018134265A1 (fr) 2017-01-17 2018-07-26 Forrest Michael David Inhibiteurs thérapeutiques du mode inverse de l'atp synthase
WO2019012149A1 (fr) 2017-07-13 2019-01-17 Forrest Michael David Modulateurs thérapeutiques du mode inverse de l'atp synthase
FR3069164B1 (fr) 2017-07-20 2020-07-24 Sederma Sa Utilisation d'un extrait bacterien pour un traitement cosmetique ou dermatologique notamment hydratant
WO2019096546A1 (fr) 2017-11-14 2019-05-23 Unilever N.V. Peptides pour augmenter la mélanine dans les mélanocytes
US11419803B2 (en) 2017-12-06 2022-08-23 Conopco, Inc. Skin darkening composition
FR3077202B1 (fr) 2018-02-01 2020-01-10 Sederma Utilisation de cyclopeptides en cosmetique
FR3079749B1 (fr) 2018-04-05 2022-10-28 Sederma Sa Utilisation d'un peptide pour un traitement de l'epiderme
FR3092759B1 (fr) 2019-02-14 2024-03-08 Sederma Sa Actif pour homogénéiser le teint, notamment des peaux à carnation olive
FR3101542B1 (fr) 2019-10-04 2022-10-28 Sederma Sa UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION
FR3101544B1 (fr) 2019-10-07 2023-09-29 Sederma Sa Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères
FR3104973B1 (fr) 2019-12-20 2022-07-22 Sederma Sa Composition cosmétique ou dermatologique agissant notamment sur les effets de la lumière bleue sur la peau et ses phanères, et utilisations associées
FR3107708B1 (fr) 2020-02-28 2025-03-07 Alganelle Microalgue recombinante capable de produire des peptides, polypeptides et protéines de KTTKS et leurs dérivés, et leurs procédé et utilisations associés
FR3108258B1 (fr) 2020-03-20 2022-08-05 Sederma Sa Composition et traitement cosmétiques pour traiter le relâchement cutané
FR3112941B1 (fr) 2020-07-30 2023-03-03 Sederma Sa Traitement cosmétique ou dermatologique à base de peptide(s) de la peau et de ses phanères
FR3115209A1 (fr) * 2020-10-21 2022-04-22 Sederma Traitement pilaire à base de peptide(s)
FR3116273B1 (fr) 2020-11-17 2023-10-27 Sederma Sa Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
FR3116274B1 (fr) 2020-11-17 2023-12-08 Sederma Sa Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
FR3116275B1 (fr) 2020-11-17 2022-09-30 Sederma Sa Tétrapeptide, composition le comprenant et son utilisation cosmétique
JP2025505052A (ja) 2021-01-24 2025-02-20 デイヴィッド フォレスト マイケル Ａｔｐ合成酵素の阻害剤－美容および治療への使用
WO2022186290A1 (fr) * 2021-03-02 2022-09-09 森永乳業株式会社 Inhibiteur de la dipeptidyle peptidase-iv
FR3124082B1 (fr) 2021-06-22 2023-11-24 Sederma Sa Utilisation de la zerumbone pour un traitement cosmétique
FR3128375B1 (fr) 2021-10-26 2024-11-29 Sederma Sa Traitement cosmétique, dermatologique ou cosméceutique, notamment propigmentant
FR3133126B1 (fr) 2022-03-07 2024-01-19 Sederma Sa Procédé d’encapsulation d’un composé hydrophobe, suspension de particules lipidiques structurées selon ce procédé et utilisations de ladite suspension
EP4292581A1 (fr) 2022-06-16 2023-12-20 Bella Aurora Labs, S.A. Composition de repigmentation capillaire
EP4385515A1 (fr) 2022-12-16 2024-06-19 Bella Aurora Labs, S.A. Composition pour la repigmentation de la peau
FR3144163A1 (fr) 2022-12-22 2024-06-28 Sederma Procédé d’obtention d’un extrait d’origine végétale, une composition contenant ledit extrait et son utilisation cosmétique
FR3152121A1 (fr) 2023-08-16 2025-02-21 Sederma Exopolysaccharide et oligosaccharides notamment pour la cosmétique
FR3160892A1 (fr) 2024-04-04 2025-10-10 Sederma Traitement cosmétique à base de pycnidione
FR3161859A1 (fr) 2024-05-03 2025-11-07 Sederma Traitement pilaire à base de peptide(s)
FR3162361A1 (fr) * 2024-05-24 2025-11-28 L'oreal Procédé de traitement des fibres kératiniques mettant en œuvre un ou plusieurs peptides particuliers ou une composition le ou les comprenant
CN119101116A (zh) * 2024-10-23 2024-12-10 广州凡岛网络科技有限公司 一种抗衰多肽及其合成方法与应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1298033C (fr) * 1985-04-16 1992-03-24 Takaharu Tanaka Derive dipeptide d'un acide gras
US4687840A (en) * 1986-02-11 1987-08-18 Texas Tech University Health Sciences Center Hypotensive active peptides
FR2702766B1 (fr) 1993-03-15 1995-04-28 Sederma Sa Nouveaux composés synthétiques, procédé de leur obtention et utilisation dans des préparations cosmétiques et dermopharamceutiques pour améliorer le bronzage.
DE69625620T2 (de) 1996-08-23 2003-08-21 Sederma S.A., Le Perray-En-Yvelines Synthetische peptide und ihre verwendung in kosmetischen oder dermopharmazeutischen zusammensetzungen
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
FR2791684B1 (fr) 1999-03-30 2001-05-11 Sederma Sa Composition cosmetiques ou dermopharmaceutiques contenant le tripeptide n-n-biotinyl-gly-his-lys pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse
FR2821086B1 (fr) 2001-02-21 2003-12-12 Sederma Sa Procede de fabrication de proteines par fermentation de microorganismes de la famille thermus, melange de proteines ainsi obtenu et composition cosmetique les contenant
FR2828811B1 (fr) 2001-08-27 2005-08-19 Sederma Sa Utilisation de l'huile de luffa cylindrica dans des compositions cosmetiques et dermopharmaceutiques relipidantes
FR2843023B1 (fr) 2002-07-30 2004-09-24 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2843963B1 (fr) 2002-08-30 2004-10-22 Sederma Sa Nouvelles molecules derivees de la noraporphine
WO2005114217A2 (fr) * 2004-04-20 2005-12-01 Medical College Of Georgia Research Institute, Inc. Systeme de transport couple na+ et ci- pour peptides opioides endogenes
FR2870244B1 (fr) * 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
FR2885522B1 (fr) 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
FR2903903B1 (fr) 2006-07-18 2008-08-29 Expanscience Laboratoires Sa Utilisation d'un hydrolysat de proteines de riz en tant que principe actif pigmentant
FR2907681B1 (fr) 2006-10-26 2012-10-19 Vincience Composition pharmaceutique et/ou cosmetique contenant des polypeptides ou des peptides.
FR2925501B1 (fr) 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2927801B1 (fr) 2008-02-22 2010-03-05 Sederma Sa Composition cosmetique hydratante comprenant une combinaison d'homarine et d'erythritol
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
CN102316886B (zh) * 2008-12-15 2014-06-18 可尔必思株式会社 抗皮肤老化肽
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
KR101222685B1 (ko) * 2009-02-12 2013-01-16 주식회사 웰스킨 다이펩타이드를 포함하는 피부 미백용 화장품 조성물
KR101080271B1 (ko) * 2009-03-31 2011-11-08 주식회사 웰스킨 다이펩타이드를 유효성분으로 포함하는 자외선에 의한 홍반반응 억제용 화장품 조성물
CN101538236B (zh) * 2009-05-08 2011-09-21 首都医科大学 月桂酰脯氨酰氨基酸甲酯作为新型促透剂的合成方法及其应用
KR20110039658A (ko) * 2009-10-12 2011-04-20 주식회사 웰스킨 다이펩타이드를 유효성분으로 포함하는 매트릭스 메탈로프로테아제-1 억제용 조성물 및 그 응용제품
FR2955326B1 (fr) 2010-01-18 2015-01-02 Sederma Sa Nouveau compose lipo-phosphate ou lipo-sulfate, compositions le contenant et utilisations cosmetiques et dermopharmaceutiques
FR2958541B1 (fr) 2010-04-08 2012-05-18 Sederma Sa Utilisation cosmetique du geranylgeranyl-2-propanol
FR2970868B1 (fr) 2011-01-31 2023-10-27 Sederma Sa Extrait d'origine vegetale, composition le contenant, procede d'obtention par culture vegetale et utilisations dans les domaines cosmetique, pharmaceutique et cosmeceutique
FR2980362B1 (fr) 2011-09-27 2013-10-04 Sederma Sa Nouvelle utilisation cosmetique d'un extrait d'albizia julibrissin et composition topique correspondante
FR2985424B1 (fr) 2012-01-10 2019-03-29 Sederma Nouvelle utilisation topique de la zerumbone
FR2985425A1 (fr) 2012-01-10 2013-07-12 Sederma Sa Nouvelle utilisation de la zerumbone

Also Published As

Publication number Publication date
US10231917B2 (en) 2019-03-19
EP2922864A2 (fr) 2015-09-30
EP4198041A3 (fr) 2023-08-09
EP2922864B1 (fr) 2023-01-04
US20170071844A1 (en) 2017-03-16
WO2014080376A3 (fr) 2014-11-06
WO2014080376A2 (fr) 2014-05-30
US9534015B2 (en) 2017-01-03
EP4198041A2 (fr) 2023-06-21
US20150274776A1 (en) 2015-10-01
US11324687B2 (en) 2022-05-10
US10660839B2 (en) 2020-05-26
US20200253852A1 (en) 2020-08-13
FR2998570A1 (fr) 2014-05-30
US20190142723A1 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
FR2998570B1 (fr) Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
FR3021319B1 (fr) Peptides, compositions les comprenant et utilisations notamment cosmetiques
IL236348A0 (en) Anti-Jagad antibodies, preparations containing them and their uses
FR3052453B1 (fr) Peptide, composition le comprenant et utilisations notamment cosmetiques
IL237625A0 (en) Antibodies against m-cam, preparations containing them and their uses
IL246361A0 (en) Antibody conjugates - antidote - trop 2, preparations containing them and their uses
BR112014027544A2 (pt) composição cosmética, processo cosmético e uso cosmético.
IL238192B (en) Antibodies that recognize alpha-synuclei, preparations containing them and their uses
IL230662A0 (en) Indazoles
IL240196A0 (en) Amide compounds, compositions comprising same and uses thereof
IL233934A0 (en) Antibodies to cd47, preparations containing them and their uses
BR112014030278A2 (pt) anticorpo, e, composição.
IL235004A0 (en) Antibodies against fgfr2, preparations containing them and their uses
EP2809345A4 (fr) Compositions immunostimulatrices, particules et applications associées
FR3000095B1 (fr) Composition comprenant du 2,3,3,3-tetrafluoropropene et du 1,2-difluoroethylene
EP2877490A4 (fr) Intéines clivées, conjugués et utilisations de celles-ci
FR3003569B1 (fr) Composition comprenant hf et 1,3,3,3-tetrafluoropropene
EP3736282C0 (fr) Peptide de pénétration cellulaire, conjugué le comprenant, et composition comprenant le conjugué
FR3003568B1 (fr) Composition comprenant hf et 3,3,3-trifluoro-2-chloropropene
EP2968107A4 (fr) Compositions cosmétiques et leurs utilisations
FR3029915B1 (fr) Tripeptides, compositions les comprenant et utilisations notamment cosmetiques
BR112014026873A2 (pt) método cosmético, composição cosmética e uso.
BR112014027025A2 (pt) composição cosmética.
BR112015013025A2 (pt) composição cosmética fotorreticulável, método de esmalte e conjunto
FR2984087B1 (fr) Element d'application cosmetique.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14